How long after stopping tirzepatide should I start retatrutide?

Most protocols recommend a 1-week washout between your last tirzepatide dose and your first retatrutide dose. This allows tirzepatide to substantially clear your system (it has a ~5-day half-life) and gives you a clean baseline. Some providers skip the washout and start retatrutide immediately the following week.

Will I gain weight during the washout week?

Possibly 1-3 lbs, primarily from increased food intake and water retention as tirzepatide's appetite-suppressing effects wear off. This is temporary and reverses quickly once retatrutide takes effect.

How soon will I know if retatrutide is working better than tirzepatide?

Most users report noticeable appetite suppression returning at the 4mg dose (weeks 6-8 of the protocol). Weight loss that exceeds your tirzepatide rate typically becomes apparent by weeks 8-12. Give it a full 12 weeks before concluding whether the switch was worthwhile.

Can I go back to tirzepatide if retatrutide doesn't work for me?

Yes. Follow the same protocol in reverse — stop retatrutide, washout 1 week, restart tirzepatide at a moderate dose. Some people find that taking a break on retatrutide actually resets their tirzepatide response.

Is it dangerous to switch between GLP-1 compounds?

Switching between GLP-1 compounds is common in clinical practice and not inherently dangerous when done with proper washout and medical supervision. The main risk is GI side effects during the transition.

Should I switch if I'm still losing weight on tirzepatide, just slowly?

Probably not. If tirzepatide is still producing 0.5-1 lb/week of weight loss, that's a working protocol. A slow loss of 0.5 lb/week is 26 lbs/year. Switch only when weight loss has truly stalled for 4+ weeks at max tolerated dose.

My provider doesn't know about retatrutide. What should I do?

Many providers are still learning about retatrutide since it's investigational. You can share the published Phase 2 study (NEJM, 2023) and TRIUMPH-4 Phase 3 results (Eli Lilly, December 2025) with your provider.

How to Switch from Tirzepatide to Retatrutide Safely (2026 Guide)

The Bottom Line

Switching from tirzepatide ("tirz") to retatrutide ("reta") is the most common GLP-1 upgrade path — typically triggered by a weight loss plateau on tirzepatide. The protocol: take your last tirzepatide dose, wait one week for washout, then start retatrutide at 2mg/week regardless of your previous tirzepatide dose. The glucagon receptor in retatrutide is pharmacologically new to your body, so the tolerance-building phase cannot be skipped. Most users report breaking through their tirzepatide plateau within 2-3 weeks of starting retatrutide, with the return of strong appetite suppression plus noticeable increases in body heat and metabolic rate. Track your transition with the Regimen app to log doses, weight, and side effects across both compounds.

When to Consider Switching

Switching from tirzepatide to retatrutide makes sense when:

You've genuinely plateaued on tirzepatide — weight loss has stalled for 4+ weeks at your maximum tolerated dose despite consistent compliance
You've optimized the basics first — protein intake (1.2-1.6g/kg/day), exercise, sleep, and hydration are all dialed in. A plateau on tirz with poor diet is not a reason to switch compounds — it's a reason to fix your diet
You've tried split dosing — some tirzepatide plateaus are actually dose-timing issues. Splitting your weekly dose into 2 injections can restart weight loss without switching compounds
You're working with a provider — someone who can monitor labs, adjust dosing, and manage the transition medically
You understand the trade-offs — retatrutide is not FDA-approved, has stronger side effects, costs more, and has less long-term safety data than tirzepatide

Warning

Retatrutide is in Phase 3 clinical trials and not FDA-approved. This switching guide is based on community protocols and provider experience, not randomized switching studies. Always work with a licensed healthcare provider when transitioning between GLP-1 compounds.

Do NOT switch if:

You've been on tirzepatide for less than 6 months (give it time)
You haven't reached at least 10mg tirzepatide (you may not have hit your effective dose yet)
Your plateau is less than 4 weeks old (normal weight fluctuations can mimic plateaus)
You're switching purely for faster results rather than because tirzepatide stopped working

Before You Switch: Checklist

Before your last tirzepatide dose, prepare:

Task	Why
Get baseline labs (metabolic panel, A1C, lipids)	Document where you are before the switch for comparison
Record your current weight, measurements, and progress photos	You'll want a clear "transition start" baseline
Source your retatrutide supply	Ensure you have enough for at least 8 weeks of titration (starting at 2mg)
Have BAC water and insulin syringes ready	Same supplies as tirzepatide reconstitution
Set up tracking in the Regimen app	Log your last tirz dose and first reta dose for a clean transition record
Discuss with your provider	Confirm they're comfortable monitoring the switch

The Switching Protocol (Week by Week)

Week	What to Do	Dose	Notes
Week 0	Take your LAST tirzepatide dose	Your current tirz dose	Normal injection, last one
Week 1	Washout — no injection	None	Both compounds have ~5-6 day half-lives. This clears most tirzepatide from your system
Week 2	First retatrutide injection	2 mg	Start low regardless of previous tirz dose
Weeks 3-5	Continue retatrutide	2 mg	Assess GI tolerance to glucagon receptor activation
Week 6	First dose increase	4 mg	If tolerating 2mg well
Weeks 7-9	Continue at 4mg	4 mg	First therapeutic dose — appetite suppression returns
Week 10	Second increase	6 mg	Glucagon effects become noticeable
Week 14+	Continue titrating	8mg, 10mg, 12mg	Increase every 4 weeks as tolerated

Pro Tip

The washout week (Week 1) is optional but recommended. Some providers have patients start retatrutide the week after their last tirzepatide dose with no washout. The risk of overlapping doses is low given the half-lives, but the washout gives a cleaner baseline and lets any lingering tirzepatide side effects clear before introducing a new compound. If you skip the washout, be extra cautious about nausea in week 1 of retatrutide — you may have residual tirzepatide activity amplifying the effect.

What to Expect During Transition

Week 1 (Washout)

Appetite will gradually return as tirzepatide clears your system
You may feel hungrier than you have in months — this is normal and temporary
Weight may tick up 1-3 lbs from increased food intake and water retention — don't panic
Some people feel more energetic as the GLP-1 suppression lifts

Weeks 2-3 (First retatrutide doses at 2mg)

Mild appetite suppression returns (less than what you felt on full-dose tirzepatide)
You may notice injection site reactions — retatrutide causes more site irritation than tirzepatide for many people
Mild nausea possible but usually less than your initial tirzepatide experience
The glucagon receptor is activating but effects are subtle at 2mg

Weeks 4-6 (Increasing to 4mg)

Appetite suppression strengthens — most users report it matching or exceeding their peak tirzepatide effect
Body heat increases, especially after meals — this is the glucagon receptor at work
Some users report the "fridge doesn't call me anymore" effect returning
Weight loss typically restarts, often breaking through the tirzepatide plateau

Weeks 7+ (6mg and beyond)

Full triple-agonist effect kicks in
Weight loss accelerates beyond what tirzepatide achieved
Side effects intensify, particularly at the 6mg to 8mg transition
Most users who switched report being glad they did, but emphasize that the first 4-6 weeks require patience

Community Insight

The most common frustration during the switch: "I felt like I went backwards during the washout and first 2 weeks." Your appetite returns, the scale may go up slightly, and it can feel like you're losing progress. This is temporary. By weeks 4-6 on reta, the vast majority of users report stronger appetite suppression than they ever had on tirz, plus the added metabolic boost from the glucagon receptor. The key is trusting the process through those uncomfortable first few weeks.

Managing Side Effects During the Switch

The transition period can cause a unique mix of side effects because your body is adapting to a new receptor profile:

Side Effect	Cause	Management
Increased hunger during washout	Tirzepatide wearing off	Eat at maintenance calories — don't restrict heavily. Focus on protein
Nausea on first reta doses	GLP-1 receptor re-stimulation + new glucagon activation	Inject after a meal, evening dosing, ginger
Injection site irritation	Retatrutide causes more site reactions	Rotate sites aggressively — see injection sites guide
Body heat / sweating	Glucagon receptor activation (new)	Normal and expected — stay hydrated, dress in layers
Mild heart rate increase	Glucagon-driven metabolic increase	Monitor weekly; usually 3-7 bpm at low doses
GI changes (diarrhea or constipation)	New compound, different receptor profile	Usually resolves in 1-2 weeks; fiber and hydration help

Pro Tip

Consider split dosing from the start of retatrutide. Instead of 2mg once per week, try 1mg twice per week. This smooths out blood levels during the critical adaptation period and reduces the nausea spike. Use the split-dose calculator to calculate exact units.

Common Mistakes When Switching

Mistake	Why It's a Problem
Starting retatrutide above 2mg	The glucagon receptor is new — your body hasn't adapted to it regardless of GLP-1/GIP tolerance from tirzepatide. Starting at 4mg+ causes severe nausea
No washout period between compounds	Risk of overlapping receptor stimulation, amplified nausea, and difficulty attributing side effects to the right compound
Panicking during the washout hunger	Appetite returning is normal and temporary. Extreme restriction during washout leads to binging and unnecessary stress
Comparing week 2 of reta to month 6 of tirz	Give retatrutide 6-8 weeks before evaluating. You didn't judge tirzepatide based on week 2 either
Not tracking the transition	Without data, you can't tell your provider (or yourself) what's working. Log every dose, weight, and side effect
Increasing reta dose too fast	Rushing to 8mg+ causes the worst side effects. The 2mg to 4mg to 6mg ramp builds tolerance to the glucagon receptor gradually

Dose Conversion: There Isn't One

There is no direct dose conversion between tirzepatide and retatrutide. They have different receptor profiles, different potencies, and different pharmacokinetics. A person on 15mg tirzepatide does not "need" 12mg retatrutide.

The correct approach is always: start at 2mg retatrutide, titrate based on your individual response.

Some rough context for expectations:

4mg retatrutide typically provides similar appetite suppression to 7.5-10mg tirzepatide
8mg retatrutide typically exceeds what 15mg tirzepatide delivered, plus the added metabolic effect
12mg retatrutide is beyond anything tirzepatide can achieve at any dose

But these are generalizations. Your response will be individual. Track and adjust.

Tracking Your Transition

Track your tirz-to-reta switch — every dose, weight change, and side effect in one timeline

Smart reminders so you never miss a dose
Progress tracking with photos and weight
Medication level curves for every compound

Regimen peptide and GLP-1 tracker app screenshot

The Regimen app is built for exactly this scenario. It tracks multiple compounds on the same timeline, so you can see:

Your last tirzepatide dose and the washout period
Your first retatrutide dose and titration progress
Weight trend across the entire transition
Side effects mapped to specific dose tiers
Blood level modeling for both compounds (see when tirz levels drop and reta levels build)

This data is invaluable for your provider visits. Instead of "I think the switch is going well," you can show actual trends.

How to Switch from Tirzepatide to Retatrutide — Protocol & Timeline